Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7605238 Human CTLA-4 antibodies and their uses

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
September 7, 2001
Date of Patent
October 20, 2009
Patent Application Number
09948939
Patent Citations Received
‌
US Patent 12084655 Packaging oligonucleotides into virus-like particles
0
‌
US Patent 11707056 Animals, repertoires and methods
0
‌
US Patent 12090147 Combination therapy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
0
‌
US Patent 12084518 Trispecific binding proteins and methods of use
0
‌
US Patent 11827704 Antibody molecules to PD-1 and uses thereof
0
‌
US Patent 11767361 Method of treating lung cancer
‌
US Patent 11840571 Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4
0
‌
US Patent 11883389 Formulations of 2-(4-chlorophenyl)-N-((2-(2,6- dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
0
‌
US Patent 11976125 B cell maturation antigen binding proteins
0
Patent Inventor Names
Tibor P. Keler
0
Alan J. Korman
0
Edward L. Halk
0
Nils Lonberg
0
Yashwant M. Deo
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7605238
Patent Primary Examiner
‌
Ilia Ouspenski

Find more entities like US Patent 7605238 Human CTLA-4 antibodies and their uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo